Dysregulation of the Keap1-Nrf2 pathway in cancer

Biochemical Society Transactions

Volumn 43, Issue , 2015, Pages 645-649

  Leinonen, Hanna M ^a   Kansanen, Emilia ^a   Pölönen, Petri ^a   Heinäniemi, Merja ^a   Levonen, Anna Liisa ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cancer; Genome; Kelch like ECH associated protein 1 (Keap1); Nuclear factor E2 related factor 2 (Nrf2); Oxidative stress; The Cancer Genome Atlas (TCGA)

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; TRANSCRIPTION FACTOR NRF2; KEAP1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

CARCINOGENESIS; EPIGENETICS; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SHORT SURVEY; APOPTOSIS; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; RADIATION RESPONSE; RADIATION TOLERANCE;

APOPTOSIS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; NEOPLASMS; NF-E2-RELATED FACTOR 2; RADIATION TOLERANCE;

EID: 84938681490     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150048     Document Type: Short Survey

References (49)

1. Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T. D., Mazur, M. and Telser, J. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44-84 CrossRef PubMed
2. Leinonen, H.M., Kansanen, E., Pölönen, P., Heinäniemi, M. and Levonen, A.-L. (2014) Role of the Keap1-Nrf2 pathway in cancer. Adv. Cancer Res. 122, 281-320 CrossRef PubMed
3. Kensler, T.W. and Wakabayashi, N. (2010) Nrf2: friend or foe for chemoprevention? Carcinogenesis 31, 90-99 CrossRef PubMed
4. Enomoto, A., Itoh, K., Nagayoshi, E., Haruta, J., Kimura, T., O'Connor, T., Harada, T. and Yamamoto, M. (2001) High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59, 169-177 CrossRef PubMed
5. Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K. and Yamamoto, M. (2001) Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol. 173, 154-160 CrossRef PubMed
6. Ramos-Gomez, M. (2003) Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice. Carcinogenesis 24, 461-467 CrossRef PubMed
7. Padmanabhan, B., Tong, K.I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.-I., Kobayashi, A., Yokoyama, S. and Yamamoto, M. (2006) Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21, 689-700 CrossRef PubMed
8. Singh, A., Misra, V., Thimmulappa, R.K., Lee, H., Ames, S., Hoque, M.O., Herman, J.G., Baylin, S.B., Sidransky, D., Gabrielson, E. et al. (2006) Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3, e420 CrossRef PubMed
9. Taguchi, K., Maher, J.M., Suzuki, T., Kawatani, Y., Motohashi, H. and Yamamoto, M. (2010) Genetic analysis of cytoprotective functions supported by graded expression of Keap1. Mol. Cell. Biol. 30, 3016-3026 CrossRef PubMed
10. Shibata, T., Kokubu, A., Gotoh, M., Ojima, H., Ohta, T., Yamamoto, M. and Hirohashi, S. (2008) Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135, 1358-1368, 1368.e1-1368.e4 CrossRef PubMed
11. Konstantinopoulos, P.A., Spentzos, D., Fountzilas, E., Francoeur, N., Sanisetty, S., Grammatikos, A.P., Hecht, J.L. and Cannistra, S.A. (2011) Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer. Cancer Res. 71, 5081-5089 CrossRef PubMed
12. Yoo, N.J., Kim, H.R., Kim, Y.R., An, C.H. and Lee, S.H. (2012) Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology 60, 943-952 CrossRef PubMed
13. Ohta, T., Iijima, K., Miyamoto, M., Nakahara, I., Tanaka, H., Ohtsuji, M., Suzuki, T., Kobayashi, A., Yokota, J., Sakiyama, T. et al. (2008) Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68, 1303-1309 CrossRef PubMed
14. Suzuki, T., Maher, J. and Yamamoto, M. (2011) Select heterozygous Keap1 mutations have a dominant-negative effect on wild-type Keap1 in vivo. Cancer Res. 71, 1700-1709 CrossRef PubMed
15. Shibata, T., Ohta, T., Tong, K.I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M. and Hirohashi, S. (2008) Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl. Acad. Sci. U.S.A. 105, 13568-13573 CrossRef PubMed
16. Shibata, T., Kokubu, A., Saito, S., Narisawa-Saito, M., Sasaki, H., Aoyagi, K., Yoshimatsu, Y., Tachimori, Y., Kushima, R., Kiyono, T. et al. (2011) NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia 13, 864-873 CrossRef PubMed
17. Kandoth, C., McLellan, M.D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J.F., Wyczalkowski, M.A. et al. (2013) Mutational landscape and significance across 12 major cancer types. Nature 502, 333-339 CrossRef PubMed
18. The Cancer Genome Atlas Network (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519-525 CrossRef PubMed
19. Genschik, P., Sumara, I. and Lechner, E. (2013) The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications. EMBO J. 32, 2307-2320 CrossRef PubMed
20. Ooi, A., Dykema, K., Ansari, A., Petillo, D., Snider, J., Kahnoski, R., Anema, J., Craig, D., Carpten, J., Teh, B.-T. et al. (2013) CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma. Cancer Res. 73, 2044-2051 CrossRef PubMed
21. Martinez, V.D., Vucic, E.A., Thu, K.L., Pikor, L.A., Hubaux, R. and Lam, W.L. (2014) Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancer. Biomed. Res. Int. 2014, 159459 PubMed
22. Lawrence, M.S., Stojanov, P., Mermel, C.H., Robinson, J.T., Garraway, L.A., Golub, T.R., Meyerson, M., Gabriel, S.B., Lander, E.S. and Getz, G. (2014) Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495-501 CrossRef PubMed
23. The Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315-322 CrossRef PubMed
24. Lawrence, M.S., Sougnez, C., Lichtenstein, L., Cibulskis, K., Lander, E., Gabriel, S.B., Getz, G., Ally, A., Balasundaram, M., Birol, I. et al. (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576-582 CrossRef PubMed
25. Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. and Kinzler, K.W. (2013) Cancer genome landscapes. Science 339, 1546-1558 CrossRef PubMed
26. Song, Y., Li, L., Ou, Y., Gao, Z., Li, E., Li, X., Zhang, W., Wang, J., Xu, L., Zhou, Y. et al. (2014) Identification of genomic alterations in oesophageal squamous cell cancer. Nature 509, 91-95 CrossRef PubMed
27. Ojesina, A.I., Lichtenstein, L., Freeman, S.S., Pedamallu, C.S., Imaz-Rosshandler, I., Pugh, T.J., Cherniack, A.D., Ambrogio, L., Cibulskis, K., Bertelsen, B. et al. (2014) Landscape of genomic alterations in cervical carcinomas. Nature 506, 371-375 CrossRef PubMed
28. Hoadley, K.A., Yau, C., Wolf, D.M., Cherniack, A.D., Tamborero, D., Ng, S., Leiserson, M.D. M., Niu, B., McLellan, M.D., Uzunangelov, V. et al. (2014) Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158, 929-944 CrossRef PubMed
29. Wang, R., An, J., Ji, F., Jiao, H., Sun, H. and Zhou, D. (2008) Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. Biochem. Biophys. Res. Commun. 373, 151-154 CrossRef PubMed
30. Zhang, P., Singh, A., Yegnasubramanian, S., Esopi, D., Kombairaju, P., Bodas, M., Wu, H., Bova, S.G. and Biswal, S. (2010) Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol. Cancer Ther. 9, 336-346 CrossRef PubMed
31. Hanada, N., Takahata, T., Zhou, Q., Ye, X., Sun, R., Itoh, J., Ishiguro, A., Kijima, H., Mimura, J., Itoh, K. et al. (2012) Methylation of the KEAP1 gene promoter region in human colorectal cancer. BMC Cancer 12, 66 CrossRef PubMed
32. Kang, K.A., Piao, M.J., Kim, K.C., Kang, H.K., Chang, W.Y., Park, I.C., Keum, Y.S., Surh, Y.J. and Hyun, J.W. (2014) Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation. Cell Death Dis. 5, e1183 CrossRef PubMed
33. Eades, G., Yang, M., Yao, Y., Zhang, Y. and Zhou, Q. (2011) miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J. Biol. Chem. 286, 40725-40733 CrossRef PubMed
34. Van Jaarsveld, M.T.M., Helleman, J., Boersma, A.W.M., van Kuijk, P.F., van Ijcken, W.F., Despierre, E., Vergote, I., Mathijssen, R.H. J., Berns, E.M.J.J., Verweij, J. et al. (2013) miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene 32, 4284-4293 CrossRef PubMed
35. Yamamoto, S., Inoue, J., Kawano, T., Kozaki, K., Omura, K. and Inazawa, J. (2014) The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors. Mol. Cancer Res. 12, 58-68 CrossRef PubMed
36. Taguchi, K., Fujikawa, N., Komatsu, M., Ishii, T., Unno, M., Akaike, T., Motohashi, H. and Yamamoto, M. (2012) Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc. Natl. Acad. Sci. U.S.A. 109, 13561-13566 CrossRef PubMed
37. Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K.I. et al. (2010) The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12, 213-223 PubMed
38. Jain, A., Lamark, T., Sjøttem, E., Larsen, K.B., Awuh, J.A., Øvervatn, A., McMahon, M., Hayes, J.D. and Johansen, T. (2010) p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J. Biol. Chem. 285, 22576-22591 CrossRef PubMed
39. Ichimura, Y., Waguri, S., Sou, Y.-S., Kageyama, S., Hasegawa, J., Ishimura, R., Saito, T., Yang, Y., Kouno, T., Fukutomi, T. et al. (2013) Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell 51, 618-631 CrossRef PubMed
40. Ma, J., Cai, H., Wu, T., Sobhian, B., Huo, Y., Alcivar, A., Mehta, M., Cheung, K.L., Ganesan, S., Kong, A.-N.T. et al. (2012) PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function. Mol. Cell. Biol. 32, 1506-1517 CrossRef PubMed
41. Hast, B.E., Goldfarb, D., Mulvaney, K.M., Hast, M.A., Siesser, P.F., Yan, F., Hayes, D.N. and Major, M.B. (2013) Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination. Cancer Res. 73, 2199-2210 CrossRef PubMed
42. Camp, N.D., James, R.G., Dawson, D.W., Yan, F., Davison, J.M., Houck, S.A., Tang, X., Zheng, N., Major, M.B. and Moon, R.T. (2012) Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein. J. Biol. Chem. 287, 6539-6550 CrossRef PubMed
43. Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D. and Zhang, D.D. (2009) Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol. Cell 34, 663-673
44. Gorrini, C., Baniasadi, P.S., Harris, I.S., Silvester, J., Inoue, S., Snow, B., Joshi, P. a, Wakeham, A., Molyneux, S.D., Martin, B. et al. (2013) BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival. J. Exp. Med. 210, 1529-1544 CrossRef PubMed
45. Ooi, A., Wong, J.-C., Petillo, D., Roossien, D., Perrier-Trudova, V., Whitten, D., Min, B.W. H., Tan, M.-H., Zhang, Z., Yang, X.J. et al. (2011) An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 20, 511-523 CrossRef PubMed
46. Adam, J., Hatipoglu, E., O'Flaherty, L., Ternette, N., Sahgal, N., Lockstone, H., Baban, D., Nye, E., Stamp, G.W., Wolhuter, K. et al. (2011) Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20, 524-537 CrossRef PubMed
47. DeNicola, G.M., Karreth, F.A., Humpton, T.J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K.H., Yeo, C.J., Calhoun, E.S. et al. (2011) Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106-109 CrossRef PubMed
48. Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M. and Motohashi, H. (2012) Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22, 66-79 CrossRef PubMed
49. Liao, H., Zhou, Q., Zhang, Z., Wang, Q., Sun, Y., Yi, X. and Feng, Y. (2012) NRF2 is overexpressed in ovarian epithelial carcinoma and is regulated by gonadotrophin and sex-steroid hormones. Oncol. Rep. 27, 1918-1924 PubMed